BECLOMETHASONE DIPROPIONATE
BECLOMETHASONE DIPROPIONATE
Approval overview BECLOMETHASONE DIPROPIONATE is listed in Drugs@FDA under application 213811 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BECLOMETHASONE DIPROPIONATE Form and strength AEROSOL, METERED;INHALATION - 0.08MG/INH Sponsor AMNEAL IRELAND LTD Submission history Latest submission status date: 2025-12-16 00:00:00.
Structured Monograph
Clinical summary
Approval overview BECLOMETHASONE DIPROPIONATE is listed in Drugs@FDA under application 213811 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BECLOMETHASONE DIPROPIONATE Form and strength AEROSOL, METERED;INHALATION - 0.08MG/INH Sponsor AMNEAL IRELAND LTD Submission history Latest submission status date: 2025-12-16 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.